These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 9178473

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Immune response to vaccinia virus recombinants expressing glycoproteins gE, gB, gH, and gL of Varicella-zoster virus.
    Kutinová L, Hainz P, Ludvíková V, Maresová L, Nĕmecková S.
    Virology; 2001 Feb 15; 280(2):211-20. PubMed ID: 11162835
    [Abstract] [Full Text] [Related]

  • 24. The synthesis and immunogenicity of varicella-zoster virus glycoprotein E and immediate-early protein (IE62) expressed in recombinant herpes simplex virus-1.
    Lowry PW, Koropchak CM, Choi CY, Mocarski ES, Kern ER, Kinchington PR, Arvin AM.
    Antiviral Res; 1997 Feb 15; 33(3):187-200. PubMed ID: 9037375
    [Abstract] [Full Text] [Related]

  • 25. Induction of anti foot and mouth disease virus T and B cell responses in cattle immunized with a peptide representing ten amino acids of VP1.
    Zamorano PI, Wigdorovitz A, Pérez Filgueira DM, Escribano JM, Sadir AM, Borca MV.
    Vaccine; 1998 Apr 15; 16(6):558-63. PubMed ID: 9569465
    [Abstract] [Full Text] [Related]

  • 26. Recombinant glycoprotein E produced in mammalian cells in large-scale as an antigen for varicella-zoster-virus serology.
    Thomsson E, Persson L, Grahn A, Snäll J, Ekblad M, Brunhage E, Svensson F, Jern C, Hansson GC, Bäckström M, Bergström T.
    J Virol Methods; 2011 Jul 15; 175(1):53-9. PubMed ID: 21540058
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Identification of neutralizing and nonneutralizing epitopes in the porcine reproductive and respiratory syndrome virus GP5 ectodomain.
    Ostrowski M, Galeota JA, Jar AM, Platt KB, Osorio FA, Lopez OJ.
    J Virol; 2002 May 15; 76(9):4241-50. PubMed ID: 11932389
    [Abstract] [Full Text] [Related]

  • 29. Immunogenicity in mice of varicella-zoster virus glycoprotein I expressed by a vaccinia virus-varicella-zoster virus recombinant.
    Ludvíková V, Kunke D, Hamsíková E, Kutinová L, Vonka V.
    J Gen Virol; 1991 Jun 15; 72 ( Pt 6)():1445-9. PubMed ID: 1646285
    [Abstract] [Full Text] [Related]

  • 30. Immunization with a DNA vaccine expressing a truncated form of varicella zoster virus glycoprotein E.
    Hasan UA, Harper DR, Wren BW, Morrow WJ.
    Vaccine; 2002 Jan 31; 20(9-10):1308-15. PubMed ID: 11818149
    [Abstract] [Full Text] [Related]

  • 31. Hybrid papillomavirus L1 molecules assemble into virus-like particles that reconstitute conformational epitopes and induce neutralizing antibodies to distinct HPV types.
    Christensen ND, Cladel NM, Reed CA, Budgeon LR, Embers ME, Skulsky DM, McClements WL, Ludmerer SW, Jansen KU.
    Virology; 2001 Dec 20; 291(2):324-34. PubMed ID: 11878901
    [Abstract] [Full Text] [Related]

  • 32. Glycosylation of immunodominant linear epitopes in the carboxy-terminal region of the caprine arthritis-encephalitis virus surface envelope enhances vaccine-induced type-specific and cross-reactive neutralizing antibody responses.
    Trujillo JD, Kumpula-McWhirter NM, Hötzel KJ, Gonzalez M, Cheevers WP.
    J Virol; 2004 Sep 20; 78(17):9190-202. PubMed ID: 15308714
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Identification of murine B-cell and T-cell epitopes of Escherichia coli outer membrane protein F with synthetic polypeptides.
    Williams KM, Bigley EC, Raybourne RB.
    Infect Immun; 2000 May 20; 68(5):2535-45. PubMed ID: 10768941
    [Abstract] [Full Text] [Related]

  • 36. Heterologous Prime-Boost Immunization Strategies Using Varicella-Zoster Virus gE mRNA Vaccine and Adjuvanted Protein Subunit Vaccine Triggered Superior Cell Immune Response in Middle-Aged Mice.
    Li D, Bian L, Cui L, Zhou J, Li G, Zhao X, Xing L, Cui J, Sun B, Jiang C, Kong W, Zhang Y, Chen Y.
    Int J Nanomedicine; 2024 May 20; 19():8029-8042. PubMed ID: 39130684
    [Abstract] [Full Text] [Related]

  • 37. Induction of neutralizing antibodies by varicella-zoster virus gpII glycoprotein expressed from recombinant vaccinia virus.
    Massaer M, Haumont M, Place M, Bollen A, Jacobs P.
    J Gen Virol; 1993 Mar 20; 74 ( Pt 3)():491-4. PubMed ID: 8383181
    [Abstract] [Full Text] [Related]

  • 38. Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus.
    Gromowski GD, Barrett AD.
    Virology; 2007 Sep 30; 366(2):349-60. PubMed ID: 17719070
    [Abstract] [Full Text] [Related]

  • 39. A novel combined vaccine based on monochimeric VLP co-displaying multiple conserved epitopes against enterovirus 71 and varicella-zoster virus.
    Wu Y, Zhu R, Xu L, Li Y, Li S, Yu H, Li S, Zhu H, Cheng T, Xia N.
    Vaccine; 2017 May 09; 35(20):2728-2735. PubMed ID: 28408118
    [Abstract] [Full Text] [Related]

  • 40. Cross-reactive and group-specific immune responses to a neutralizing epitope of the human respiratory syncytial virus fusion protein.
    Corvaisier C, Bourgeois C, Pothier P.
    Arch Virol; 1997 May 09; 142(6):1073-86. PubMed ID: 9228999
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.